Pharmacy Times® interviewed Amesh Adalja, MD, FIDSA, FACP, FACEP, a senior scholar at the Johns Hopkins Center for Health Security, on how the proposed EUA for Johnson & Johnson’s single-dose vaccine may impact the COVID-19 vaccine distribution and administration process.
Pharmacy Times® interviewed Kenneth Thorpe, PhD, the former deputy assistant secretary at the HHS during the Clinton administration, on how pandemic preparedness lessons from COVID-19 may help to tackle the antimicrobial resistance health crisis.
Pharmacy Times® interviewed David Silverstein, JD, MS, a partner in Axinn’s Intellectual Property and FDA practice groups, on what may be coming to market in the rapidly growing cell therapy space, and the role pharmacists may play in this emerging landscape.
Pharmacy Times® interviewed J. David Robertson, PhD, director of University of Missouri Research Reactor, on a new collaboration with Advanced Accelerator Applications International to develop a targeted therapy for certain types of cancerous tumors.
Crystal Lewis, a third-year pharmacy student at Washington State University, about her top 3 study snacks for pharmacy students.
Pharmacy Times® interviewed Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at the NCPA, on his outlook on the future of the COVID-19 vaccination rollout under the Biden administration.
Pharmacy Times® interviewed Susan Swindells, MD, of the University of Nebraska Medical Center, on the impact of the recently FDA-approved once-monthly, long-acting HIV regimen on how providers care for patients with the virus.
Pharmacy Times® interviewed Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at the NCPA, on how the Biden administration’s launch of the Federal Retail Pharmacy Program may affect the COVID-19 vaccination rollout.
Pharmacy Times® interviewed Kim White, MBA, vice president of Numerof & Associates, on how changes in business strategies in hospitals due to the COVID-19 pandemic may affect how hospital pharmacies conduct their business.
Despite concerns about increased transmissibility, experts are optimistic that the current vaccines will provide some level of protection when combined with the body's immune response.
Pharmacy Times® interviewed Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at the NCPA, on the Biden administration’s announcement of the launch of the Federal Retail Pharmacy Program for COVID-19 vaccination.
Pharmacy Times® interviewed Lee Rosebush, JD, PharmD, MS, MBA, partner at Baker & Hostetler, on an interactive state-by-state vaccination rollout guide his law firm created to help pharmacies navigate the various state approaches to COVID-19 vaccination efforts.
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic the next steps for his CAEL-101 findings, a treatment for patients living with amyloid light chain amyloidosis.
Pharmacy Times® interviewed Alex Hontos, JD, partner at Dorsey & Whitney, on the executive order President Biden signed directing agencies to utilize the Defense Production Act, among other tools, to prioritize production of COVID-19 vaccines and material.
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic his recent CAEL-101 findings, and how it can help shape treatment for patients living with amyloid light chain amyloidosis.
Pharmacy Times® interviewed Sandra Divarco, JD, partner at McDermott Will & Emery, on the complex considerations facing hospitals, health systems, and pharmacies during COVID-19 vaccinations.
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about what CAEL-101 is, how it works, and how it is used to treat patients with amyloid light chain amyloidosis.
Pharmacy Times interviewed Jason Valent, MD, of the Cleveland Clinic about his new research surrounding CAEL-101, a treatment for patients living with amyloid light chain amyloidosis.
Steve Moore, PharmD, chairman of the Pharmacists Society of the State of New York, said the Federal Retail Pharmacy Program will work alongside his state’s own rollouts to get shots in arms.
Pharmacy Times® interviewed Nurisha Wade, MBA, and Farah Towfic, PharmD, MBA, of US Pharmacopeia, on how the release of the COVID-19 Vaccine Handling Toolkit may help pharmacists quickly and safely vaccinate.
Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how the COVID-19 pandemic is going to impact cancer mortality.
Pharmacy Times interviewed Randall A. Oyer, MD, president of the Association of Community Cancer Centers, about how screening can help reduce cancer deaths.
Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what’s on the horizon of interest for independent pharmacy in 2021.
Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on the steps necessary to support the long-term viability of independent community pharmacies.
Despite rising cancer death rates during the coronavirus disease 2019 (COVID-19) pandemic, Randall A. Oyer, MD, said it's not too late to reverse it.
Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on solutions that can help support independent community pharmacies now and in the future.
In an interview, Nishita Hira, PharmD, CSP, clinical program manager at AllianceRx Walgreens Prime, discussed the role specialty pharmacists can play during the COVID-19 vaccine rollout.
Pharmacy Times® interviewed Micah Cost, PharmD, MS, who was recently selected as the new chief executive officer of PQA, on his plans for the future of the organization.
Pharmacy Times interviewed Rob LaHayne, CEO of TouchCare, on how communicating the safety and efficacy of COVID-19 vaccines to the public is an essential piece of the rollout.
Pharmacy Times® interviewed Brian Nightengale, president of Good Neighbor Pharmacy, on what the implementation of the recent unanimous SCOTUS ruling on Rutledge v. PCMA may look like.
